Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Belluscura PLC ( (GB:BELL) ) has issued an update.
Belluscura PLC has announced ongoing discussions with Omaha Value, Inc., AI Ventures, Inc., and other potential investors regarding proposed fundraising, which have yet to be concluded. In response to immediate cash requirements, Belluscura LLC has terminated the employment of 15 out of 25 employees in the US, while retaining key staff to ensure customer order fulfillment. Additionally, CEO Bob Rauker and non-executive director Ric Piper have resigned from the board, and the company’s shares remain suspended on AIM due to incomplete 2024 Annual Report and Accounts.
More about Belluscura PLC
Belluscura PLC is a leading medical device developer that specializes in lightweight and portable oxygen enrichment technology.
Average Trading Volume: 1,011,982
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.01M
For a thorough assessment of BELL stock, go to TipRanks’ Stock Analysis page.